NOS3 and endothelial dysfunction: Moreover, despite the administration of L-NAME, an eNOS blocker, to the hypertensive cohort, no distinct indications of endothelial dysfunction were reported ex vivo, potentially attributed to a washout effect or resynthesis of eNOS, and in line with a previous study by our laboratory [36].